Dietary polyunsaturated fatty acids and inflammation: The role of phospholipid biosynthesis

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 21167-21188

  Raphael, William ^a   Sordillo, Lorraine M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Cyclooxygenase; Diet; Eicosanoid; Fatty acid; Inflammation; Lipid mediator; Lipoxygenase; Phospholipid

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; 15 HYDROPEROXYARACHIDONIC ACID; CARDIOLIPIN; CYTIDINE DIPHOSPHATE DIGLYCERIDE; DIACYLGLYCEROL ACYLTRANSFERASE; DOCOSAHEXAENOIC ACID; GLUCOSE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; ICOSAPENTAENOIC ACID; LEUKOTRIENE; LINOLENIC ACID; LIPOXIN; LIPOXYGENASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATIDIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHOETHANOLAMINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE; PHOSPHOSERINE; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; SATURATED FATTY ACID; THROMBOXANE; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL;

DIET SUPPLEMENTATION; ENZYME REGULATION; ENZYME SYNTHESIS; ESTERIFICATION; FAT INTAKE; GLUCOSE HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; INSULIN RESISTANCE; LIPID ABSORPTION; LIPID COMPOSITION; LIPID METABOLISM; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIET; FATTY ACIDS, UNSATURATED; HUMANS; INFLAMMATION; PHOSPHOLIPIDS;

EID: 84886257922     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141021167     Document Type: Review

References (117)

1. Calder, P.C. Fatty acids and inflammation: The cutting edge between food and pharma. Eur. J. Pharmacol. 2011, 668, S50-S58.
2. Calder, P.C.; Albers, R.; Antoine, J.M.; Blum, S.; Bourdet-Sicard, R.; Ferns, G.; Folkerts, G.; Friedmann, P.; Frost, G.; Guarner, F. Inflammatory disease processes and interactions with nutrition. Br. J. Nutr. 2009, 101, 1-45.
3. Simopoulos, A.P. Evolutionary aspects of diet, the ω-6/ω-3 ratio and genetic variation: Nutritional implications for chronic diseases. Biomed. Pharmacother. 2006, 60, 502-507.
4. Contreras, G.A.; Sordillo, L.M. Lipid mobilization and inflammatory responses during the transition period of dairy cows. Comp. Immunol. Microbiol. Infect. Dis. 2011, 34, 281-289.
5. Sordillo, L.M.; Contreras, G.A.; Aitken, S.L. Metabolic factors affecting the inflammatory response of periparturient dairy cows. Anim. Health Res. Rev. 2009, 10, 53-63.
6. Harris, W.S.; Poston, W.C.; Haddock, C.K. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007, 193, 1-10.
7. Simons, K.; Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1, 31-39.
8. Stillwell, W.; Wassall, S.R. Docosahexaenoic acid: Membrane properties of a unique fatty acid. Chem. Phys. Lipids 2003, 126, 1-27.
9. Poulsen, R.C.; Gotlinger, K.H.; Serhan, C.N.; Kruger, M.C. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and ω-3 intake. Am. J. Hematol. 2008, 83, 437-445.
10. Bruss, M.L. Lipids and Ketones. In Clinical Biochemistry of Domestic Animals, 6th ed.; Kaneko, J.J., Harvey, J.W., Bruss, M.L., Eds.; Elsevier: St. Louis, MO, USA, 2008; pp. 81-115.
11. Bauman, D.E.; Harvatine, K.J.; Lock, A.L. Nutrigenomics, rumen-derived bioactive fatty acids, and the regulation of milk fat synthesis. Annu. Rev. Nutr. 2011, 31, 299-319.
12. Vance, D.E.; Vance, J.E. Phospholipid Biosynthesis in Eukaryotes. In Biochemistry of Lipids, Lipoproteins and Membranes, 5th ed.; Vance, D.E., Vance, J.E., Eds.; Elsevier: St. Louis, MO, USA, 2008; pp. 213-244.
13. Loewen, C.J.R. Lipids as conductors in the orchestra of life. F1000 Biol. Rep. 2012, doi:10.3410/B4-4.
14. Young, B.P.; Shin, J.J.H.; Orij, R.; Chao, J.T.; Li, S.C.; Guan, X.L.; Khong, A.; Jan, E.; Wenk, M.R.; Prinz, W.A. Phosphatidic acid is a pH biosensor that links membrane biogenesis to metabolism. Sci. Signal. 2010, 329, 1085-1088.
15. Blasbalg, T.L.; Hibbeln, J.R.; Ramsden, C.E.; Majchrzak, S.F.; Rawlings, R.R. Changes in consumption of ω-3 and ω-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93, 950-962.
16. Cordain, L.; Eaton, S.B.; Sebastian, A.; Mann, N.; Lindeberg, S.; Watkins, B.A.; O'Keefe, J.H.; Brand-Miller, J. Origins and evolution of the Western diet: Health implications for the 21st century. Am. J. Clin. Nutr. 2005, 81, 341-354.
17. Bang, H.O.; Dyerberg, J.; Hjørne, N. The composition of food consumed by greenland eskimos. Acta Med. Scand. 1976, 200, 69-73.
18. Elias, P.M.; Brown, B.E.; Ziboh, V.A. The permeability barrier in essential fatty acid deficiency: Evidence for a direct role for linoleic acid in barrier function. J. Invest. Dermatol. 1980, 74, 230-233.
19. Delion, S.; Chalon, S.; Hérault, J.; Guilloteau, D.; Besnard, J.C.; Durand, G. Chronic dietary a-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J. Nutr. 1994, 124, 2466-2476.
20. Guillou, H.; Zadravec, D.; Martin, P.G.P.; Jacobsson, A. The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog. Lipid Res. 2010, 49, 186-199.
21. Rule, DC.; Broughton, K.S.; Shellito, S.M.; Maiorano, G Comparison of muscle fatty acid profiles and cholesterol concentrations of bison, beef cattle, elk, and chicken. J. Anim. Sci. 2002, 80, 1202-1211.
22. White, S.L.; Bertrand, J.A.; Wade, MR.; Washburn, S.P.; Green, J.T., Jr.; Jenkins, T.C. Comparison of fatty acid content of milk from Jersey and Holstein cows consuming pasture or a total mixed ration. J. Dairy Sci. 2001, 84, 2295-2301.
23. Douglas, G; Rehage, J.; Beaulieu, A.; Bahaa, A.; Drackley, J. Prepartum nutrition alters fatty acid composition in plasma, adipose tissue, and liver lipids of periparturient dairy cows. J. Dairy Sci. 2007, 90, 2941-2959.
24. Contreras, G.; Mattmiller, S.; Raphael, W.; Gandy, J.; Sordillo, L. Enhanced n-3 phospholipid content reduces inflammatory responses in bovine endothelial cells. J. Dairy Sci. 2012, 95, 7137-7150.
25. Lawrence, T.; Gilroy, D.W. Chronic inflammation: A failure of resolution? Int. J. Exp. Pathol. 2007, 88, 85-94.
26. Virtanen, J.K.; Mozaffarian, D.; Chiuve, S.E.; Rimm, E.B. Fish consumption and risk of major chronic disease in men. Am. J. Clin. Nutr. 2008, 88, 1618-1625.
27. Galli, C.; Risé, P. Fish consumption, o-3 fatty acids and cardiovascular disease. The science and the clinical trials. Nutr. Health 2009, 20, 11-20.
28. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354, 447-455.
29. Rose, DP.; Connolly, J.M. Q-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther. 1999, 83, 217-244.
30. Trebble, T.; Arden, N.K.; Stroud, M.A.; Wootton, S.A.; Burdge, GC.; Miles, E.A.; Ballinger, A.B.; Thompson, R.L.; Calder, P.C. Inhibition of tumour necrosis factor-a and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br. J. Nutr. 2003, 90, 405-412.
31. Bosch, J.; Gerstein, H.C.; Dagenais, G.R.; Diaz, R.; Dyal, L.; Jung, H.; Maggiono, A.P.; Probstfield, J.; Ramachandran, A.; Riddle, M.C.; et al N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N. Engl. J. Med. 2012, 367, 309-318.
32. Rizos, EC.; Ntzani, E.E.; Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between o-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 2012, 308, 1024-1033.
33. Arterburn, L.M.; Hall, E.B.; Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83, 1467S-1476S.
34. De Mello, V.D.F.; Kolehmanien, M.; Schwab, U.; Pulkkinen, L.; Uusitupa, M. Gene expression of peripheral blood mononuclear cells as a tool in dietary intervention studies: What do we know so far? Mol. Nutr. Food Res. 2012, 56, 1160-1172.
35. Andreyev, A.Y.; Fahy, E.; Guan, Z.; Kelly, S.; Li, X.; McDonald, J.G.; Milne, S.; Myers, D.; Park, H.; Ryan A.; et al. Subcellular organelle lipidomics in TLR-4-activated macrophages. J. Lipid Res. 2010, 51, 2785-2797.
36. Quehenberger, O.; Armando, A.M.; Brown, A.H.; Milne, S.B.; Myers, D.S.; Merrill, A.H.; Bandyopadhyay, S.; Jones, K.N.; Kelly, S.; Shaner, R.L. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 2010, 51, 3299-3305.
37. Dowhan, W.; Bogdanov, M.; Mileykovskaya, E. Functional Roles of Lipids in Membranes. In Biochemistry of Lipids, Lipoproteins and Membranes, 5th ed.; Vance, D.E., Vance, J.E., Eds.; Elsevier: St. Louis, MO, USA, 2008; pp. 1-38.
38. Paradies, G.; Petrosillo, G.; Paradies, V.; Reiter, R.J.; Ruggiero, F.M. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal Res. 2010, 48, 297-310.
39. Musatov, A.; Robinson, N.C. Susceptibility of mitochondrial electron-transport complexes to oxidative damage. Focus on cytochrome coxidase. Free Radic. Res. 2012, 46, 1313-1326.
40. Yin, H.; Zhu, M. Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases. Free Radic. Res. 2012, 46, 959-974.
41. Corl, C.; Gandy, J.; Sordillo, L. Platelet activating factor production and proinflammatory gene expression in endotoxin-challenged bovine mammary endothelial cells. J. Dairy Sci. 2008, 91, 3067-3078.
42. Lee, J.Y.; Sohn, K.H.; Rhee, S.H.; Hwang, D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001, 276, 16683-16689.
43. Suganami, T.; Tanimoto-Koyama, K.; Nishida, J.; Itoh, M.; Yuan, X.; Mizuarai, S.; Kotani, H.; Yamaoka, S.; Miyake, K.; Aoe S.; et al. Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 84-91.
44. Kim, F.; Pham, M.; Luttrell, I.; Bannerman, D.D.; Tupper, J.; Thaler, J.; Hawn, T.R.; Raines, E.W.; Schwartz, M.W. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 2007, 100, 1589-1596.
45. Wong, S.W.; Kwon, M.J.; Choi, A.M.; Kim, H.P.; Nakahira, K.; Hwang, D.H. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 2009, 284, 27384-27392.
46. Li, X.; Yu, Y.; Funk, C.D. Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4). FASEB J. 2013, doi:10.1096/fj.13-235333 fj.13-235333.
47. Edwards, I.J.; Flaherty, J.T. Ω-3 fatty acids and PPARg in cancer. PPAR Res. 2008, 2008, 358052:1-358052:14.
48. Dumlao, D.S.; Buczynski, M.W.; Norris, P.C.; Harkewicz, R.; Dennis, E.A. High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2011, 1811, 724-736.
49. Dubois, R.N.; Abramson, S.B.; Crofford, L.; Gupta, R.A.; Simon, L.S.A. van de Putte, L.B.; Lipsky, P.E. Cyclooxygenase in biology and disease. FASEB J. 1998, 12, 1063-1073.
50. Kuhn, H.; Thiele, B.J. The diversity of the lipoxygenase family: Many sequence data but little information on biological significance. FEBS Lett. 1999, 449, 7-11.
51. Serhan, C.N.; Petasis, N.A. Resolvins and protectins in inflammation resolution. Chem. Rev. 2011, 111, 5922-5943.
52. Calder, P.C. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, S1505-S1519.
53. Altmann, R.; Hausmann, M.; Spöttl, T.; Gruber, M.; Bull, A.W.; Menzel, K.; Vogl, D.; Herfarth, H.; Schölmerich, J.; Falk, W.; et al. 13-Oxo-ODE is an endogenous ligand for PPARγ in human colonic epithelial cells. Biochem. Pharmacol. 2007, 74, 612-622.
54. Natarajan, R.; Reddy, M.A.; Malik, K.U.; Fatima, S.; Khan, B.V. Signaling mechanisms of nuclear factor-κB-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1408-1413.
55. Ogawa, E.; Owada, Y.; Ikawa, S.; Adachi, Y.; Egawa, T.; Nemoto, K.; Suzuki, K.; Hishinuma, T.; Kawashima, H.; Kondo, H.; et al. Epidermal FABP (FABP5) regulates keratinocyte differentiation by 13(S)-HODE-mediated activation of the NF-κB signaling pathway. J. Invest. Dermatol. 2011, 131, 604-612.
56. Ylä-Herttuala, S.; Rosenfeld, M.E.; Parthasarathy, S.; Glass, C.K.; Sigal, E.; Witztum, J.L.; Steinberg, D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 1990, 87, 6959-6963.
57. Xu, L.; Davis, T.A.; Porter, N.A. Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes. J. Am. Chem. Soc. 2009, 131, 13037-13044.
58. Yoshida, Y.; Niki, E. Hydroxyoctadecadienoic Acid (HODE) as a Marker of Linoleic Acid Oxidation. In Biomarkers for Antioxidant Defense and Oxidative Damage: Principles and Practical Applications; Aldini, G., Yeum, K.J., Niki, E., Russell, R.M., Eds.; Wiley: Ames, IA, USA, 2010; pp. 85-97.
59. Dussault, P.; Lee, I.Q. The total synthesis of 15(S)-HPETE (hydroperoxyeicosatetraenoic acid). J. Org. Chem. 1992, 57, 1952-1954.
60. Ramsden, C.E.; Ringel, A.; Feldstein, A.E.; Taha, A.Y.; MacIntosh, B.A.; Hibbeln, J.R.; Majchrzak-Hong, S.F.; Faurot, K.R.; Rapoport, S.I.; Cheon, Y.; et al. Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot Essent. Fat. Acids 2012, 87, 135-141.
61. Kelley, D.S.; Taylor, P.C.; Nelson, G.J.; Mackey, B.E. Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men. Lipids 1998, 33, 125-130.
62. Hardardottir, I.; Kinsella, J.E. Tumor necrosis factor production by murine resident peritoneal macrophages is enhanced by dietary n-3 polyunsaturated fatty acids. Biochim. Biophys. Acta 1991, 1095, 187-195.
63. Zuo, X.; Shureiqi, I. Eicosanoid profiling in colon cancer: Emergence of a pattern. Prostaglandins Lipid Mediat. 2013, 104-105, 139-143.
64. Wang, D.; DuBois, R.N. Prostaglandins and cancer. Gut 2006, 55, 115-122.
65. Vangaveti, V.; Baune, B.T.; Kennedy, R.L. Review: Hydroxyoctadecadienoic acids: Novel regulators of macrophage differentiation and atherogenesis. Ther. Adv. Endocrinol. Metab. 2010, 1, 51-60.
66. Spite, M.; Norling, L.V.; Summers, L.; Yang, R.; Cooper, D.; Petasis, N.A.; Flower, R.J.; Perretti, M.; Serhan, C.N. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 2009, 461, 1287-1291.
67. Norling, L.V.; Dalli, J.; Flower, R.J.; Serhan, C.N.; Perretti, M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: Receptor-dependent actions. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 1970-1978.
68. Rong, S.; Cao, Q.; Liu, M.; Seo, J.; Jia, L.; Boudyguina, E.; Gebre, A.K.; Colvin, P.L.; Smith, T.L.; Murphy, R.C.; et al. Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis. J. Lipid Res. 2012, 53, 686-695.
69. Cyrus, T.; Witztum, J.L.; Rader, D.J.; Tangirala, R.; Fazio, S.; Linton, M.; Funk, C.D. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J. Clin. Invest. 1999, 103, 1597-1604.
70. Johnson, G.H.; Fritsche, K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: A systematic review of randomized controlled trials. J. Acad. Nutr. Diet. 2012, 112, 1029-1041.
71. Gertow, K.; Nobili, E.; Folkersen, L.; Newman, J.W.; Pedersen, T.L.; Ekstrand, J.; Swedenborg, J.; Kuhn, H.; Wheelock, C.E.; Hansson, G.K.; et al. 12- and 15-lipoxygenases in human carotid atherosclerotic lesions: Associations with cerebrovascular symptoms. Atherosclerosis 2011, 215, 411-416.
72. Huo, Y.; Zhao, L.; Hyman, M.C.; Shashkin, P.; Harry, B.L.; Burcin, T.; Forlow, S.B.; Stark, M.A.; Smith, D.F.; Clarke, S.; et al. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004, 110, 2024-2031.
73. Stachowska, E.; Dziedziejko, V.; Safranow, K.; Jakubowska, K.; Olszewska, M.; Machaliñski, B.; Chlubek, D. Effect of conjugated linoleic acids on the activity and mRNA expression of 5- and 15-lipoxygenases in human macrophages. J. Agric. Food Chem. 2007, 55, 5335-5342.
74. Contreras, G.; Raphael, W.; Mattmiller, S.; Gandy, J.; Sordillo, L. Nonesterified fatty acids modify inflammatory response and eicosanoid biosynthesis in bovine endothelial cells. J. Dairy Sci. 2012, 95, 5011-5023.
75. Brinckmann, R.; Schnurr, K.; Heydeck, D.; Rosenbach, T.; Kolde, G.; Kühn, H. Membrane translocation of 15-lipoxygenase in hematopoietic cells is calcium-dependent and activates the oxygenase activity of the enzyme. Blood 1998, 91, 64-74.
76. Zou, H.; Yuan, C.; Dong, L.; Sidhu, R.S.; Hong, Y.H.; Kuklev, D.V.; Smith, W.L. Human cyclooxygenase-1 activity and its responses to COX inhibitors are allosterically regulated by nonsubstrate fatty acids. J. Lipid Res. 2012, 53, 1336-1347.
77. Kühn, H.; Belkner, J.; Suzuki, H.; Yamamoto, S. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J. Lipid Res. 1994, 35, 1749-1759.
78. Soberman, R.; Harper, T.; Betteridge, D.; Lewis, R.; Austen, K. Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid ω-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuclear leukocytes. J. Biol. Chem. 1985, 260, 4508-4515.
79. Kuhn, H.; Barnett, J.; Grunberger, D.; Baecker, P.; Chow, J.; Nguyen, B.; Bursztyn-Pettegrew, H.; Chan, H.; Sigal, E. Overexpression, purification and characterization of human recombinant 15-lipoxygenase. Biochim. Biophys. Acta Lipids Lipid Metab. 1993, 1169, 80-89.
80. Norris, P.C.; Dennis, E.A. Ω-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc. Natl. Acad. Sci. USA 2012, 109, 8517-8522.
81. Hung, N.D.; Kim, M.R.; Sok, D.E. Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis. Inflammation 2011, 34, 147-160.
82. Levy, B.D.; Bonnans, C.; Silverman, E.S.; Palmer, L.J.; Marigowda, G.; Israel, E. Diminished lipoxin biosynthesis in severe asthma. Am. J. Respir. Crit. Care Med. 2005, 172, 824-830.
83. Healy, D.A.; Wallace, F.A.; Miles, E.A.; Calder, P.C.; Newsholme, P. Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 2000, 35, 763-768.
84. Rees, D.; Miles, E.A.; Banerjee, T.; Wells, S.J.; Roynette, C.E.; Wahle, K.W.; Calder, P.C. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men. Am. J. Clin. Nutr. 2006, 83, 331-342.
85. Woodworth, H.L.; McCaskey, S.J.; Duriancik, D.M.; Clinthorne, J.F.; Langohr, I.M.; Gardner, E.M.; Fenton, J.I. Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis. Cancer Res. 2010, 70, 7960-7969.
86. Fitzgerald, G.A. Coxibs and cardiovascular disease. N. Engl. J. Med. 2004, 351, 1709-1711.
87. Cheng, Y.; Austin, S.C.; Rocca, B.; Koller, B.H.; Coffman, T.M.; Grosser, T.; Lawson, J.A.; FitzGerald, G.A. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002, 296, 539-541.
88. Xiong, A.; Yu, W.; Tiwary, R.; Sanders, B.G.; Kline, K. Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells. Mol. Nutr. Food Res. 2012, 56, 923-934.
89. Kitessa, S.M.; Gulati, S.K.; Ashes, J.R.; Fleck, E.; Scott, T.W.; Nichols, P.D. Utilisation of fish oil in ruminants: II. Transfer of fish oil fatty acids into goats' milk. Anim. Feed Sci. Technol. 2001, 89, 201-208.
90. Okuyama, H.; Kobayashi, T.; Watanabe, S. Dietary fatty acids-The n-6/n-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan. Prog. Lipid Res. 1996, 35, 409-457.
91. Kris-Etherton, P.M.; Harris, W.S.; Appel, L.J. Fish consumption, fish oil, ω-3 fatty acids, and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2003, 23, e20-e30.
92. Emken, E.A.; Adlof, R.O.; Gulley, R.M. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim. Biophys. Acta BBA Lipids Lipid Metab. 1994, 1213, 277-288.
93. Van den Top, A.M.; Geelen, M.J.H.; Wensing, T.; Wentink, G.H.; van'T Klooster, A.T.; Beynen, A.C. Higher postpartum hepatic triacylglycerol concentrations in dairy cows with free rather than restricted access to feed during the dry period are associated with lower activities of hepatic glycerolphosphate acyltransferase. J. Nutr. 1996, 126, 76-85.
94. Contreras, G.A.; O'Boyle, N.J.; Herdt, T.H.; Sordillo, L.M. Lipomobilization in periparturient dairy cows influences the composition of plasma nonesterified fatty acids and leukocyte phospholipid fatty acids. J. Dairy Sci. 2010, 93, 2508-2516.
95. Kaplan, A.; Lee, V.F. Serum lipid levels in infants and mothers at parturition. Clin. Chim. Acta 1965, 12, 258-263.
96. Shuster, D.; Lee, E.; Kehrli, M. Jr. Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation. Am. J. Vet. Res. 1996, 57, 1569-1575.
97. Iwasaki, Y.; Yamane, T. Enzymatic synthesis of structured lipids. Adv. Biochem. Eng. Biotechnol. 2004, 90, 760-760.
98. Triggiani, M.; Oriente, A.; Marone, G. Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. J. Immunol. 1994, 152, 1394-1403.
99. Strawford, A.; Antelo, F.; Christiansen, M.; Hellerstein, M.K. Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O. Am. J. Physiol. Endocrinol. Metab. 2004, 286, E577-E588.
100. Hodson, L.; Skeaff, C.M.; Fielding, B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008, 47, 348-380.
101. Kennedy, E.P.; Weiss, S.B. The function of cytidine coenzymes in the biosynthesis of phospholipides. J. Biol. Chem. 1956, 222, 193-214.
102. Liu, Q.; Siloto, R.M.P.; Lehner, R.; Stone, S.J.; Weselake, R.J. Acyl-CoA:diacylglycerol acyltransferase: Molecular biology, biochemistry and biotechnology. Prog. Lipid Res. 2012, 51, 350-377.
103. The LIPID MAPS-Nature Lipidomics Gateway. Available online: http://www.lipidmaps.org (accessed on 24 May 2012).
104. Kanter, J.E.; Kramer, F.; Barnhart, S.; Averill, M.M.; Vivekanandan-Giri, A.; Vickery, T.; Li, L.O.; Becker, L.; Yuan, W.; Chait, A.; et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc. Natl. Acad. Sci. USA 2012, 109, E715-E724.
105. Takeuchi, K.; Reue, K. Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E1195-E1209.
106. Bionaz, M.; Loor, J.J. ACSL1, AGPAT6, FABP3, LPIN1, and SLC27A6 are the most abundant isoforms in bovine mammary tissue and their expression is affected by stage of lactation. J. Nutr. 2008, 138, 1019-1024.
107. Loor, J.J.; Dann, H.M.; Everts, R.E.; Oliveira, R.; Green, C.A.; Guretzky, N.A.J.; Rodriguez-Zas, S.L.; Lewin, H.A.; Drackley, J.K. Temporal gene expression profiling of liver from periparturient dairy cows reveals complex adaptive mechanisms in hepatic function. Physiol. Genomics 2005, 23, 217-226.
108. Bladergroen, B.A.; Wensing, T.; van Golde, L.M.G.; Geelen, M.J.H. Reversible translocation of CTP:phosphocholine cytidylyltransferase from cytosol to membranes in the adult bovine liver around parturition. Biochim. Biophys. Acta Lipids Lipid Metab. 1998, 1391, 233-240.
109. Xu, A.; Wang, Y.; Xu, J.Y.; Stejskal, D.; Tam, S.; Zhang, J.; Wat, N.M.S.; Wong, W.K.; Lam, K.S.L. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem. 2006, 52, 405-413.
110. Sharma, N.K.; Langberg, K.A.; Mondal, A.K.; Das, S.K. Phospholipid biosynthesis genes and susceptibility to obesity: Analysis of expression and polymorphisms. PLoS One 2013, 8, e65303.
111. Lands, W.E. Metabolism of glycerolipides: A comparison of lecithin and triglyceride synthesis. J. Biol. Chem. 1958, 231, 883-888.
112. Mulligan, C.M.; Sparagna, G.C.; le, C.H.; de Mooy, A.B.; Routh, M.A.; Holmes, M.G.; Hickson-Bick, D.L.; Zarini, S.; Murphy, R.C.; Xu, F.Y.; et al. Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart. Cardiovasc. Res. 2012, 94, 460-468.
113. Shindou, H.; Hishikawa, D.; Harayama, T.; Yuki, K.; Shimizu, T. Recent progress on acyl CoA: Lysophospholipid acyltransferase research. J. Lipid Res. 2009, 50, S46-S51.
114. Coleman, R.A.; Lewin, T.M.; van Horn, C.G.; Gonzalez-Baró, M.R. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J. Nutr. 2002, 132, 2123-2126.
115. Turkish, A.; Sturley, S.L. Regulation of triglyceride metabolism. I. Eukaryotic neutral lipid synthesis: "Many ways to skin ACAT or a DGAT". Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G953-G957.
116. Yen, C.-L.E.; Stone, S.J.; Koliwad, S.; Harris, C.; Farese, R.V. Thematic review series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 2008, 49, 2283-2301.
117. Zammit, V.A.; Buckett, L.K.; Turnbull, A.V.; Wure, H.; Proven, A. Diacylglycerol acyltransferases: Potential roles as pharmacological targets. Pharmacol. Ther. 2008, 118, 295-302